Ancient Humans Had Hepatitis B

Analyses of more than 300 ancient human genomes show that Hepatitis B virus has infected humans for at least 4,500 years and has much older origins than modern viral genomes would suggest.

Written byAbby Olena, PhD
| 4 min read

Register for free to listen to this article
Listen with Speechify
0:00
4:00
Share

Illustration of Hepatitis viral particlesISTOCK, SARATHSASIDHARANMore than 250 million people worldwide are currently living with Hepatitis B virus (HBV), which infects the liver. While hundreds of thousands of them die each year of HBV-related complications such as cirrhosis and liver cancer, the virus’s origins are still not well understood. In a study published today (May 9) in Nature, researchers find evidence of HBV in human genomes from Eurasian remains dating from around 200 to 4,500 years ago, suggesting that people have been living with the virus for thousands of years.

“In the Hep. B field, we’ve always thought that HBV was an ancient pathogen of humans, but there hasn’t been any evidence” older than about 400 years, until this study, Margaret Littlejohn, a senior medical scientist at the Victorian Infectious Diseases Reference Laboratory of the Doherty Institute in Melbourne, Australia, who did not participate in the work, tells The Scientist. “It’s certainly a great leap for the field.”

The work began with an investigation by Eske Willerslev, an evolutionary geneticist at the University of Cambridge and the University of Copenhagen, and colleagues designed to understand human population history across an 8,000-kilometer-wide swath of Europe and Asia. The researchers sequenced the genomes of more than 200 ancient humans, whose remains ranged from 11,000 to 500 years ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • abby olena

    As a freelancer for The Scientist, Abby reports on new developments in life science for the website. She has a PhD from Vanderbilt University and got her start in science journalism as the Chicago Tribune’s AAAS Mass Media Fellow in 2013. Following a stint as an intern for The Scientist, Abby was a postdoc in science communication at Duke University, where she developed and taught courses to help scientists share their research. In addition to her work as a science journalist, she leads science writing and communication workshops and co-produces a conversational podcast. She is based in Alabama.  

    View Full Profile
Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies